Clinical Efficacy of Thymalfasin Adjuvant Therapy in Treatment of Patients with Severe Community-acquired Pneu-monia and Its Effects on Cellular Immune Function and Inflammatory Reaction

REN Mao; XIE Yun; WANG Tian-yi; HAN Bing-chao; GAO Cong-hui; LIU Xiao-hu; REN Jian-ping; GAO Xiu-hua

doi:10.3969/j.issn.1002-3429.2022.01.006

Home>Articles>Clinical Efficacy of Thymalfasin Adjuvant Therapy in Treatment of Patients with Severe Community-acquired Pneu-monia and Its Effects on Cellular Immune Function and Inflammatory Reaction

DOI: 10.3969/j.issn.1002-3429.2022.01.006

Clinical Efficacy of Thymalfasin Adjuvant Therapy in Treatment of Patients with Severe Community-acquired Pneu-monia and Its Effects on Cellular Immune Function and Inflammatory Reaction

REN Mao

XIE Yun

WANG Tian-yi

HAN Bing-chao

GAO Cong-hui

LIU Xiao-hu

REN Jian-ping

GAO Xiu-hua

Machine-generated Keywords：

Publication Date：2022-01-22

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 20-23 )

Clinical Misdiagnosis & Mistherapy

ISTIC

ISSN：1002-3429

Year, Vol.(Issue)：2022,35(1)